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MDR strain evolutionAims and objectives: Resistant-, multidrug resistant- (MDR) and even extensively drug resis-
tant- (XDR) Mycobacterium tuberculosis complex (MTBC) strains have emerged worldwide
and representa serious challenge forglobal tuberculosis (TB) control. Interestingly, high rates
of MDR TB have been associated with particular phylogenetic lineages of the MTBC such as
the Beijing lineage and the strong clonal expansion of particular MDR strains in Eastern Eur-
ope. However, a systematic investigation of the evolution and cross border transmission of
particular highly transmissibleMDR strains in Eastern Europehas not been performed so far.
Methods: To address this question, an in-depth analysis was performed of the population
structure (based on 24 loci MIRU-VNTR-typing and spoligotyping) of strains from different
settings in Eastern Europe, such as Uzbekistan, Turkmenistan, and Kazakhstan.
Results: The results showed that twomajor clones of the Beijing lineage are the drivers of the
MDR epidemic in Eastern Europe. In addition, retrospective investigation of an MDR strain
collection from Germany using MIRU-VNTR and IS6110 RFLP patterns revealed that both
clones were circulating for more than 15 years. In-depth analysis of genome characteristics
confirmed the longitudinal transmission of the twomajor MDR clones and allowed the iden-
tificationofparticularbeneficial combinationsofmutationspotentially compensating for the
fitness defect of the MDR/XDR strains. Moreover, these allele combinations coincidewith an
enhanced transmissibility compared with other circulating MDR/XDR strain types and pro-
mote the selection of extremely drug resistant but also highly virulent MTBC strain variants.
Conclusion: Taken together, these data argue strongly for an expansion of particularMDRBei-
jing clones in Eastern Europe that started at least 15 years ago. Evolution and selection over
the past years has resulted in ‘‘hyper transmissible’’ MDR-TB strains that have the potential
to spread rapidly and, thus, further complicate TB control.
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